Prospective evaluation of Nardilysin for the early detection of patients with Acute Coronary Syndrome

Prospective evaluation of Nardilysin for the early detection of patients with Acute Coronary Syndrome - Nardi-ACS Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024577

Enrollment

1400

Registered

2016-10-27

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACS, Takotsubo syndrome, pulmonary embolism, Aortic dissection, others

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with informed concent

Exclusion criteria

Exclusion criteria: patients without informed concent

Design outcomes

Primary

Measure	Time frame
ACS, serum NRDc concentration, high sensitive troponin I	—

Secondary

Measure	Time frame
Acute aortic dissection, pulmonary embolism, Takotsubo syndrome, troponin T, MACE (30 days after onset)	—

Countries

Japan

Contacts

Public ContactHiroki Shiomi

Kyoto University Graduate School of Medicine Dept. of Cardiovascular Medicine

hishiomi@kuhp.kyoto-u.ac.jp075-751-3187

Outcome results